Sigma-Aldrich acquires Cerilliant

Monday, 10 January, 2011

Sigma-Aldrich has acquired all outstanding shares of Cerilliant of Round Rock, Texas to strengthen the company’s analytical chemistry product portfolio and to continue to deliver on its strategic growth plans.

Cerilliant, a supplier of high-quality reference standards and materials, provides products that support the clinical diagnostics, environmental, nutraceutical, pharmaceutical, forensic and clinical toxicology markets.

The company expects this acquisition to be neutral to mildly accretive to earnings per share in 2011. Cerilliant has been a portfolio company of Argenta Partners of Dallas, Texas, for the past 10 years.

Cerilliant brings to Sigma-Aldrich around 2800 products and 30 years of expertise in the design, development, synthesis, characterisation and packaging of analytical standards, calibrators, controls and certified reference materials that are used in a wide range of analytical applications.

Related News

Australia to begin treaty negotiations on association to Horizon Europe

To give Australian organisations access to the world's largest pooled research fund in 2027,...

Vaxxas partners with AI company Profenso to support quality assurance

A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in...

SA Police seize 'clandestine laboratory' drug-making equipment

Following a search at Woodville North last week, Western District Police have made one of the...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd